World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
30841
World Ranking
11314
National Ranking
5807

Overview

Paul H. Lange is affiliated with the University of Washington in the United States. Their research primarily spans the field of Medicine, with specific focus on multiple subfields including Radiology, Nuclear Medicine and Imaging, Neurology, History, Public Health, Environmental and Occupational Health, and Surgery.

Their work addresses several main topics within medical and scientific research. These topics include:

  • Advances in Oncology and Radiotherapy
  • History of Medical Practice
  • Medical History and Research
  • Organ Donation and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Neurological Complications and Syndromes

Paul H. Lange has contributed to several recent publications. Notable papers include:

  • "A history of the Society of Urologic Oncology," published in 2021 in Urologic Oncology Seminars and Original Investigations
  • "1278: MANAGEMENT OF PATIENTS WHO PROGRESS TO BRAIN DEATH AND ITS IMPACT ON ORGANS TRANSPLANTED PER DONOR," published in 2022 in Critical Care Medicine
  • "Tribute to Michael Droller MD," published in 2025 in Urologic Oncology Seminars and Original Investigations

These publications reflect a diverse interest ranging from medical history and oncology to critical care and organ transplantation.

Their frequent co-authors comprise several researchers who have collaborated on multiple projects, specifically:

  • Paul F. Schellhammer
  • Michael S. Cookson
  • Michael J. Droller
  • James Matson
  • Virginia McBride

Paul H. Lange's papers have appeared predominantly in the following publication venues:

  • Urologic Oncology Seminars and Original Investigations
  • Critical Care Medicine

Their research outputs contribute to academic discussions in diverse areas of medicine, particularly focusing on oncology, organ transplantation, and neurological issues within clinical practice.

Best Publications

  • Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease: A Prospective Multicenter Clinical Trial

    W.J. Catalona;A.W. Partin;K.M. Slawin;M.K. Brawer

  • Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

    Fisher Cj;Dhainaut Jf;Opal Sm;Pribble Jp

  • Prostate cancer. Clinical practice guidelines in oncology.

    James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby

  • Screening for Prostatic Carcinoma with Prostate Specific Antigen

    Michael K. Brawer;Michael P. Chetner;Jeanette Beatie;David M. Buchner

  • Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

    Akash Kumar;Ilsa Coleman;Colm Morrissey;Xiaotun Zhang

  • The Value of Serum Prostate Specific Antigen Determinations Before and after Radical Prostatectomy

    Paul H. Lange;Cesar J. Ercole;Deborah J. Lightner;Elwin E. Fraley

  • NCCN clinical practice guidelines in oncology: kidney cancer.

    Robert J Motzer;Neeraj Agarwal;Clair Beard;Graeme B Bolger

  • Purification of a human prostate specific antigen. Commentary

    M. C. Wang;L. A. Valenzuela;G. P. Murphy;T. M. Chu

  • Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

    William J Catalona;Paula C Southwick;Kevin M Slawin;Alan W Partin

  • Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

    Mark S. Soloway;Joseph V. Briggman;Gennaro A. Carpinito;Gerald W. Chodak

  • Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic Cancer

    Cesar J. Ercole;Paul H. Lange;Mary Mathisen;Rei K. Chiou

  • Bladder cancer. Clinical practice guidelines in oncology.

    Peter E. Clark;Neeraj Agarwal;Matthew C. Biagioli;Mario A. Eisenberger

  • Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone ☆

    Martine P Roudier;Lawrence D True;Celestia S Higano;Hubert Vesselle

  • A molecular correlate to the Gleason grading system for prostate adenocarcinoma

    Lawrence True;Ilsa Coleman;Sarah Hawley;Ching Ying Huang

  • Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers

    Akash Kumar;Thomas A. White;Alexandra P. MacKenzie;Nigel Clegg

  • LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.

    Holly M. Nguyen;Robert L. Vessella;Colm Morrissey;Lisha G. Brown

  • Prostate specific antigen and local recurrence after radical prostatectomy.

    Deborah J. Lightner;Paul H. Lange;Pratap K. Reddy;Lee Moore

  • Androgenic Induction of Prostate-Specific Antigen Gene Is Repressed by Protein-Protein Interaction Between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP

    Naohide Sato;Marianne D. Sadar;Nicholas Bruchovsky;Fahri Saatcioglu

  • Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines

    Peter R. Carroll;J. Kellogg Parsons;Gerald Andriole;Robert R. Bahnson

  • Cell–cell interaction in prostate gene regulation and cytodifferentiation

    Alvin Y. Liu;Lawrence D. True;Leah LaTray;Peter S. Nelson

Frequent Co-Authors

Robert L. Vessella
Robert L. Vessella University of Washington
Peter S. Nelson
Peter S. Nelson Fred Hutchinson Cancer Research Center
Lawrence D. True
Lawrence D. True University of Washington
Celestia S. Higano
Celestia S. Higano University of Washington
Kurt Amplatz
Kurt Amplatz University of Minnesota
Daniel W. Lin
Daniel W. Lin University of Washington
Tomasz M. Beer
Tomasz M. Beer Oregon Health & Science University
William J. Catalona
William J. Catalona Northwestern University
Juan Rosai
Juan Rosai Memorial Sloan Kettering Cancer Center
Leroy Hood
Leroy Hood University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a variety of related online degrees and healthcare career pathways. For high school students interested in healthcare, best online schools for high school students provide early exposure to health information management and establish a strong foundation for future studies.

For those seeking faster entry into the healthcare field, completing a low cost medical coding and billing online program offers affordable, flexible training for in-demand administrative roles within hospitals and clinics.

Nursing also presents a popular pathway, and aspiring advanced practice nurses can consider cheap np programs that balance high-quality education with reduced tuition costs. Those seeking to begin or advance their nursing careers have a wealth of affordable online nursing programs to choose from, opening possibilities from registered nurse to specialized practitioner roles.

Online health degrees offer flexible, cost-effective options for a wide range of learners, supporting meaningful careers in medicine and beyond.

Best Scientists Citing Paul H. Lange

Trending Scientists